Halozyme Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HALO for the last quarter is 230.04 M USD, and it's 6.48% higher compared to the previous quarter. The net income of Q4 23 is 85.39 M USD.